Steven Kaplan, MD, is Chief Medical Advisor at Aspargo Labs and also serves as Director of the Men’s Wellness Program, Mount Sinai Health System and Professor, Icahn School of Medicine at Mount Sinai. He is an internationally recognized authority and one of the primary thought leaders in the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction, and female urology.  

He has over 1000 publications including 600 peer-reviewed articles and 90 book chapters. His landmark study, published in JAMA in 2006, changed the way medications are used in the treatment of men with symptoms related to both benign prostate enlargement and bladder dysfunction. He has made over 340 presentations in more than 35 countries. He is the co-author of five books and is on the Editorial Board of numerous journals including Urology, Journal of Urology, and Urology Times. 

Dr. Kaplan is a member of more than 30 professional organizations, been awarded 5 NIH grants and has received over $13 million in research funding.  He serves as both member and/or Chair of numerous study sections for the NIH and more recently, he chaired the NIDDK Prostate Strategic Planning Committee and currently Chairs the AUA Research Committee on Advocacy. He also has served on the American Urologic Association Guidelines Panel for BPH.  He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation. Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons.